Gastroenterology
Volume 137, Issue 3 , Pages 824-833 , September 2009

Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location

  • Gwen Murphy

      Affiliations

    • Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, NIH, Rockville, Maryland
    • Infection and Immunoepidemiology Branch, National Cancer Institute, NIH, Rockville, Maryland
    • Corresponding Author InformationReprint requests Address requests for reprints to: Gwen Murphy, PhD, MPH, Infections and Immunoepidemiology Branch, DCEG, National Cancer Institute, 6120 Executive Blvd., EPS 7067, Rockville, Maryland 20892. fax: (301) 402-0817
    • ,
  • Ruth Pfeiffer

      Affiliations

    • Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland
    • ,
  • M. Constanza Camargo

      Affiliations

    • Infection and Immunoepidemiology Branch, National Cancer Institute, NIH, Rockville, Maryland
    • ,
  • Charles S. Rabkin

      Affiliations

    • Infection and Immunoepidemiology Branch, National Cancer Institute, NIH, Rockville, Maryland

Received 27 February 2009 ,Accepted 7 May 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. El-Omar EM, Carrington M, Chow W-H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402
  3. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424–1433
  4. Blaser MJ. Science, medicine, and the future—Helicobacter pylori and gastric diseases. Br Med J. 1998;316:1507–1510
  5. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–768
  6. Epstein-Barr virus. IARC Monogr Eval Carcinog Risks Hum. 1997;70:347–373
  7. Szekely L, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;90:5455–5459
  8. Hsieh JJ, Henkel T, Salmon P, et al. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol. 1996;16:952–959
  9. Huen DS, Henderson SA, Croom-Carter D, et al. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 1995;10:549–560
  10. Stewart S, Dawson CW, Takada K, et al. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway. Proc Natl Acad Sci U S A. 2004;101:15730–15735
  11. Burgess DE, Woodman CB, Flavell KJ, et al. Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom. Br J Cancer. 2002;86:702–704
  12. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol. 2000;53:255–261
  13. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest. 1994;71:73–81
  14. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A. 1994;91:9131–9135
  15. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol. 1992;140:769–774
  16. Herrmann K, Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol. 2003;199:140–145
  17. Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–380
  18. Akiba S, Koriyama C, Herrera-Goepfert R, et al. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008;99:195–201
  19. Sousa H, Pinto-Correia AL, Medeiros R, et al. Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance?. World J Gastroenterol. 2008;14:4347–4351
  20. Koriyama C, Akiba S, Iriya K, et al. Epstein-Barr virus-associated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in Sao Paulo. Jpn J Cancer Res. 2001;92:911–917
  21. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma (An attempt at a histo-clinical classification). Acta Pathol Microbiol Scand. 1965;64:31–49
  22. Harris R. Metan: fixed- and random-effects meta-analysis. Stata J. 2008;8:3–28
  23. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209–212
  24. Lipsey MW, Wilson DB. Practical meta-analysis (Volume applied social research methods series). Vol. 49. Thousand Oaks, CA: Sage Publications; 2001;
  25. Analyzing and presenting results. In:  Deeks ER,  Higgins MF,  Altman WC editor. Cochrane handbook for systematic reviews of interventions 4.2.6 (updated September 2006). Chichester, W Sussex, UK: Wiley Publications; 2006;
  26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748
  27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  28. Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–1160
  29. Ferlay J, Bray F, Pisani P. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. Lyon: IARC Press; 2004;
  30. Tobias A. Assessing the influence of a single study in meta-analysis. Stat Tech Bull. 1999;47:15–17
  31. Lima VP, de Lima MA, Andre AR, et al. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol. 2008;14:884–891
  32. Nakamura Y, Yanai H, Kitoh T, et al. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer. Hepatogastroenterology. 2008;55:41–45
  33. Koriyama C, Shinkura R, Hamasaki Y, et al. Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients. Eur J Cancer Prev. 2001;10:69–75
  34. Shousha S, Luqmani YA. Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa. J Clin Pathol. 1994;47:695–698
  35. Ojima H, Fukuda T, Nakajima T, et al. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J Cancer Res. 1997;88:262–266
  36. Herrera-Goepfert R, Akiba S, Koriyama C, et al. Epstein-Barr virus-associated gastric carcinoma: evidence of age-dependence among a Mexican population. World J Gastroenterol. 2005;11:6096–6103
  37. Tokunaga M, Land CE, Uemura Y, et al. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993;143:1250–1254
  38. Wang HH, Wu MS, Shun CT, et al. Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection. Hepatogastroenterology. 1999;46:1214–1219
  39. Selves J, Bibeau F, Brousset P, et al. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology. 1996;28:121–127
  40. Chang MS, Lee JH, Kim JP, et al. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Pathol Int. 2000;50:486–492
  41. Baas IO, van Rees BP, Musler A, et al. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol. 1998;51:662–666
  42. Corvalan A, Koriyama C, Akiba S, et al. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer. 2001;94:527–530
  43. Nishikawa J, Yanai H, Hirano A, et al. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol. 2002;37:825–829
  44. Tanigawa H, Uesugi H, Mitomi H, et al. Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy (Comparison with gastroduodenostomy). Am J Clin Pathol. 2000;114:354–363
  45. Anwar M, Koriyama C, Naveed IA, et al. Epstein-Barr virus detection in tumors of upper gastrointestinal tract (An in situ hybridization study in Pakistan). J Exp Clin Cancer Res. 2005;24:379–385
  46. Grogg KL, Lohse CM, Pankratz VS, et al. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003;16:641–651
  47. Kattoor J, Koriyama C, Akiba S, et al. Epstein-Barr virus-associated gastric carcinoma in southern India: a comparison with a large-scale Japanese series. J Med Virol. 2002;68:384–389
  48. Luo B, Wang Y, Wang XF, et al. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma. World J Gastroenterol. 2006;12:1842–1848
  49. Morewaya J, Koriyama C, Akiba S, et al. Epstein-Barr virus-associated gastric carcinoma in Papua, New Guinea. Oncol Rep. 2004;12:1093–1098
  50. Oda K, Koda K, Takiguchi N, et al. Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer. 2003;6:173–178
  51. Vo QN, Geradts J, Gulley ML, et al. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol. 2002;55:669–675
  52. Yuen ST, Chung LP, Leung SY, et al. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol. 1994;18:1158–1163
  53. Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol. 2005;40:570–577
  54. Chang MS, Lee HS, Kim HS, et al. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J Pathol. 2003;199:447–452
  55. van Beek J, zur Hausen A, Klein Kranenbarg E, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664–670
  56. Shin WS, Kang MW, Kang JH, et al. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. Am J Clin Pathol. 1996;105:174–181
  57. Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int. 1997;47:360–367
  58. Minoura-Etoh J, Gotoh K, Sato R, et al. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol. 2006;55:905–911
  59. Wu MS, Shun CT, Wu CC, et al. Epstein-Barr virus-associated gastric carcinomas: relation to H pylori infection and genetic alterations. Gastroenterology. 2000;118:1031–1038
  60. Yanai H, Murakami T, Yoshiyama H, et al. Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol. 1999;29:39–43
  61. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007;56:918–925
  62. Zhang Y, Molot R. Severe gastritis secondary to Epstein-Barr viral infection (Unusual presentation of infectious mononucleosis and associated diffuse lymphoid hyperplasia in gastric mucosa). Arch Pathol Lab Med. 2003;127:478–480
  63. Saxena A, Nath Prasad K, Chand Ghoshal U, et al. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Scand J Gastroenterol. 2008;43:669–674
  64. Kim YS, Paik SR, Kim HK, et al. Epstein-Barr virus and CD21 expression in gastrointestinal tumors. Pathol Res Pract. 1998;194:705–711
  65. Koriyama C, Akiba S, Minakami Y, et al. Environmental factors related to Epstein-Barr virus-associated gastric cancer in Japan. J Exp Clin Cancer Res. 2005;24:547–553
  66. Dougherty SH, Foster CA, Eisenberg MM. Stomach cancer following gastric surgery for benign disease. Arch Surg. 1982;117:294–297
  67. Yanai H, Shimizu N, Nagasaki S, et al. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol. 1999;94:1582–1586
  68. Uozaki H, Fukayama M. Epstein-Barr virus and gastric carcinoma—viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol. 2008;1:198–216
  69. Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002;5:213–219
  70. Freedman ND, Chow WH, Gao YT, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007;56:1671–1677
  71. Derakhshan MH, Liptrot S, Paul J, et al. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17-year delayed development in females. Gut. 2009;58:16–23
  72. Hirayama T. Descriptive and analytical epidemiology of nasopharyngeal cancer. IARC Sci Publ. 1978;167–189
  73. Chang ET, Zheng T, Lennette ET, et al. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis. 2004;189:2271–2281
  74. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70:375–382
  75. Shapira J, Peylan-Ramu N. Burkitt's lymphoma. Oral Oncol. 1998;34:15–23
  76. Oksuzyan A, Juel K, Vaupel JW, et al. Men: good health and high mortality (Sex differences in health and aging). Aging Clin Exp Res. 2008;20:91–102
  77. Crimmins EM, Finch CE. Commentary: do older men and women gain equally from improving childhood conditions?. Int J Epidemiol. 2006;35:1270–1271
  78. Owens IP. Ecology and evolution (Sex differences in mortality rate). Science. 2002;297:2008–2009

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Ireland-Northern Ireland-National Cancer Institute Cancer Consortium and the Health Research Board of Ireland (to G.M.) and by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute.

 To view this article’s video abstract, go to the AGA's YouTube Channel.

PII: S0016-5085(09)00745-8

doi: 10.1053/j.gastro.2009.05.001

Gastroenterology
Volume 137, Issue 3 , Pages 824-833 , September 2009

Article Tools

* Image Usage & Resolution